Trine Ahlgreen

Title: Trine Ahlgreen: Innovator in Insulin Administration

Introduction

Trine Ahlgreen is a notable inventor based in Frederiksberg C, Denmark. He has made significant contributions to the field of medical treatment, particularly in the administration of insulin for individuals with diabetes. His innovative approach aims to improve the management of blood glucose levels through a novel administration regime.

Latest Patents

Trine Ahlgreen holds a patent for an invention titled "Administration regime." This invention relates to a novel method useful in the treatment of diseases or conditions where the administration of insulin is beneficial. The patent outlines a long-acting or ultra-long-acting insulin designed for treating conditions requiring insulin administration. The process involves several steps, including optionally providing a blood sample, taking a single fasting blood glucose measurement, determining the insulin dose based on that measurement, and administering the insulin accordingly.

Career Highlights

Trine Ahlgreen is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to focus on innovative solutions that enhance the quality of life for individuals managing diabetes. His patent reflects his commitment to advancing medical treatments and improving patient outcomes.

Collaborations

Trine Ahlgreen collaborates with talented professionals in his field, including Thue Johansen and Ann Marie Ocampo Francisco. These collaborations foster an environment of innovation and shared expertise, contributing to the development of effective medical solutions.

Conclusion

Trine Ahlgreen's contributions to insulin administration represent a significant advancement in diabetes care. His innovative patent and work at Novo Nordisk A/S highlight his dedication to improving treatment methods for individuals in need.